Image For Activity Cover
Anaplastic Thyroid Cancer
Course Description
Join the Endocrine Cancers SIG for a webinar on the diagnosis, surgical management, and latest therapies for anaplastic thyroid cancer.
Target Audience

The intended audience for this activity includes a wide range of health care professionals; Physician-in-practice, Fellows, Resident and anyone who may deem this presentation beneficial.

Learning Objectives
1. Describe the important tests for diagnosing and staging anaplastic thyroid cancer.
2. Identify important factors for the optimal surgical management of anaplastic thyroid cancer.
3. Describe evidence-based therapies for anaplastic thyroid cancer.
Faculty
Speakers:

  • Electron Kebebew, MD, FACS, Harry A. Oberhelman Jr and Mark L. Welton Professor and Chief of General Surgery, Stanford University Health

  • Maria Cabanillas, MD, Oncologic Endocrinologist University of Texas MD Anderson Cancer Center

Moderators:

  • Zeina Hannoush, MD Assistant Clinical Professor University of Miami Health System
  • Samira Sadowski, MD Physician-Scientist Early Investigator National Cancer Institute, Center for Cancer Research
Summary
Availability: Retired
Cost: Member: $0.00
Non-Member: $45.00
In-Training Member: $0.00
Resident Member: $0.00
Resident Non-Member: $45.00
Credit Offered:
No Credit Offered
Recommended
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Powered By